Ruizhen Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ruizhen Zhang has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Kai Zong
4 shared publicationsAojing Deng
3 shared publicationsLiangfu Zhao
3 shared publicationsLina Han
3 shared publicationsChaojing Chai
2 shared publicationsDanxue Zhang
2 shared publications
Latest Publications
- 5 November 2025
- Published by Elsevier in Microporous and Mesoporous Materials
- Vol. 402
Influence of solvent effect on the amine-free synthesis of high-silica ZSM-5 with the investigation of mechanism
- 5 November 2025
- Published by Elsevier in Microporous and Mesoporous Materials
- Vol. 402
Influence of solvent effect on the amine-free synthesis of high-silica ZSM-5 with the investigation of mechanism
- 16 September 2025
- Published by Elsevier in Journal of Solid State Chemistry
- Vol. 353
Sodium salt-assisted transcrystal synthesis of low-silica ZSM-5 in the amine-free system with the investigation of mechanism
- 16 September 2025
- Published by Elsevier in Journal of Solid State Chemistry
- Vol. 353
Sodium salt-assisted transcrystal synthesis of low-silica ZSM-5 in the amine-free system with the investigation of mechanism
- 1 October 2020
- Published by Elsevier in Journal of Solid State Chemistry
- Vol. 290
Seed-assisted synthesis and characterization of nano and micron ZSM-5 molecular sieves in template-free system
- 1 October 2020
- Published by Elsevier in Journal of Solid State Chemistry
- Vol. 290
Seed-assisted synthesis and characterization of nano and micron ZSM-5 molecular sieves in template-free system
- Open Access
Determination of protein binding for novel 2‐(2‐hydroxypropanamido)‐5‐trifluoromethyl benzoic acid enantiomers to rats, dogs, and humans plasma by UPLC‐MS/MS
R‐/S‐2‐(2‐hydroxypropanamido)‐5‐trifluoromethyl benzoic acid (R‐/S‐HFBA) is a novel COX inhibitor with remarkable anti‐inflammatory and antiplatelet aggregation activities, but no gastrointestinal toxicity. In our previous study, the different pharmacokinetic profiles of the two enantiomers in rats were observed after administration of R‐HFBA and S‐HFBA. Stereoselective protein binding of the two enantiomers may be a reason for the different pharmacokinetic behaviors. In this study, we developed and validated an UPLC‐MS/MS method for determining stereoselective binding of HFBA enantiomers to rat, dog, and human plasma in vitro. Chromatographic separation was achieved by gradient elution with a flow rate of 0.4 mL/min. MS/MS detection was operated in positive electrospray using multiple reaction monitoring (MRM) mode. The method was proved to be linear over the concentration range of 0.005 to 10 μg/mL with a lower limit of quantification of 0.005 μg/mL. The developed method was successfully employed to the plasma protein binding study of HFBA enantiomers. Equilibrium dialysis method was applied to assess drug‐plasma protein interactions. The results showed that the enantiomers were both extensively bound to three species plasma and protein binding of R‐/S‐HFBA was concentration dependent. R‐HFBA and S‐HFBA showed significant species difference among rat, dog, and human plasma and stereoselective plasma protein binding.
Open AccessDetermination of protein binding for novel 2‐(2‐hydroxypropanamido)‐5‐trifluoromethyl benzoic acid enantiomers to rats, dogs, and humans plasma by UPLC‐MS/MS
R‐/S‐2‐(2‐hydroxypropanamido)‐5‐trifluoromethyl benzoic acid (R‐/S‐HFBA) is a novel COX inhibitor with remarkable anti‐inflammatory and antiplatelet aggregation activities, but no gastrointestinal toxicity. In our previous study, the different pharmacokinetic profiles of the two enantiomers in rats were observed after administration of R‐HFBA and S‐HFBA. Stereoselective protein binding of the two enantiomers may be a reason for the different pharmacokinetic behaviors. In this study, we developed and validated an UPLC‐MS/MS method for determining stereoselective binding of HFBA enantiomers to rat, dog, and human plasma in vitro. Chromatographic separation was achieved by gradient elution with a flow rate of 0.4 mL/min. MS/MS detection was operated in positive electrospray using multiple reaction monitoring (MRM) mode. The method was proved to be linear over the concentration range of 0.005 to 10 μg/mL with a lower limit of quantification of 0.005 μg/mL. The developed method was successfully employed to the plasma protein binding study of HFBA enantiomers. Equilibrium dialysis method was applied to assess drug‐plasma protein interactions. The results showed that the enantiomers were both extensively bound to three species plasma and protein binding of R‐/S‐HFBA was concentration dependent. R‐HFBA and S‐HFBA showed significant species difference among rat, dog, and human plasma and stereoselective plasma protein binding.
- 1 May 2012
- Published by Elsevier in Optics Communications
- Vol. 285 (10-11) , 2656-2659
Optimization of dichromatic filters based on photonic heterostructures of Si/MgF2
- 1 May 2012
- Published by Elsevier in Optics Communications
- Vol. 285 (10-11) , 2656-2659
Optimization of dichromatic filters based on photonic heterostructures of Si/MgF2